OrensJB, EstenneM, ArcasoyS, ConteJV, CorrisP, EganJJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update–a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 2006; 25(7):745–755.
ShennibH, MassardG. Airway complications in lung transplantation. Ann Thorac Surg, 1994; 57(2):506–511.
8.
KshettryVR, KroshusTJ, HertzMI, HunterDW, ShumwaySJ, BolmanRM3rd. Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg, 1997; 63(6):1576–1583.
9.
LimaO, CooperJD, PetersWJ, AyabeH, TownsendE, LukSC, GoldbergM. Effects of methylprednisolone and azathioprine on bronchial healing following lung autotransplantation. J Thorac Cardiovasc Surg, 1981; 82(2):211–215.
10.
TakaoM, KatayamaY, OnodaK, TanabeH, HiraiwaT, MizutaniT, et al. Significance of bronchial mucosal blood flow for the monitoring of acute rejection in lung transplantation. J Heart Lung Transplant, 1991; 10(6):956–966.
11.
RuttmannE, UlmerH, MarcheseM, DunstK, GeltnerC, MargreiterR, et al. Evaluation of factors damaging the bronchial wall in lung transplantation. J Heart Lung Transplant, 2005; 24(3):275–281.
12.
WederW, InciI, KoromS, KestenholzPB, HillingerS, EichC, et al. Airway complications after lung transplantation: risk factors, prevention and outcome. Eur J Cardiothorac Surg, 2009; 35(2):293–298.
13.
ColbyC, McAfeeS, SacksteinR, FinkelsteinD, FishmanJ, SpitzerT. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant, 1999; 24(8):897–902.
14.
BrumS, NolascoF, SousaJ, FerreiraA, PossanteM, PintoJR, et al. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil. Transplant Proc, 2008; 40(3):752–754.
MansouriA, LurieAA. Concise review: methemoglobinemia. Am J Hematol, 1993; 42(1):7–12.
17.
DarlingR, RoughtonF. The effect of methemoglobin on the equilibrium between oxygen and hemoglobin. Am J Physiol, 1942; 137:56.
18.
Ash-BernalR, WiseR, WrightSM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore), 2004; 83(5):265–273.
19.
UmbreitJ. Methemoglobin: it's not just blue: a concise review. Am J Hematol, 2007; 82(2):134–144.
20.
Da-SilvaSS, SajanIS, UnderwoodJP3rd. Congenital methemoglobinemia: a rare cause of cyanosis in the newborn: a case report. Pediatrics, 2003; 112(2):e158–e161.
21.
Worster-DroughtC, WhiteJC, SargentF. Familial idiopathic methaemoglobinaemia, associated with mental deficiency and neurological abnormalities. Br Med J, 1953; 2(4828):114–118.
22.
LerouxA, JunienC, KaplanJ, BambergerJ. Generalised deficiency of cytochrome b5 reductase in congenital methaemoglobinaemia with mental retardation. Nature, 1975; 258(5536):619–620.
23.
HironoH. Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Lipids, 1980; 15(4):272–275.
24.
NagaiT, ShirabeK, YubisuiT, TakeshitaM. Analysis of mutant NADH-cytochrome b5 reductase: apparent type III methemoglobinemia can be explained as type I with an unstable reductase. Blood, 1993; 81(3):808–814.
25.
HegeshE, HegeshJ, KaftoryA. Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med, 1986; 314(12):757–761.
26.
AkhtarJ, JohnstonBD, KrenzelokEP. Mind the gap. J Emerg Med, 2007; 33(2):131–132.
